Poultry Vaccines Market: By Vaccine, By Application, and Region Forecast 2019-2030

Poultry Vaccines Market Size, Share, Growth, Trends, and Global Industry Analysis: By Vaccine (Inactivated Vaccines, Live Attenuated Vaccines, and Others), By Application (Mareka's Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Avian Influenza, Coccidiosis, Mycoplasma, and Others), and Region Forecast 2019-2030

Poultry Vaccines Market size was valued at US$ 2.1 billion in 2023 and is expanded to grow at a significant CAGR of 5.9% from 2024-2030. The disease outbreaks in poultry drive the poultry vaccine market. Growing farmed poultry can speed up the spread of infectious pathogens among birds, such as the avian influenza virus, which has the great promise to cause widespread mortality and significant economic losses in poultry. However, poultry is accepted as a good source of protein. The poultry industry will be forced to intensify production in many countries, leading to more significant numbers of farms that house birds at elevated densities. Hence the regulatory bodies are accelerating the approval process for various vaccines related to veterinary health. Increasing awareness among veterinary practitioners about animal vaccination, growing meat consumption, and rising government initiatives for food safety is boosting the market. The growing poultry population, combined with the rising prevalence of avian diseases, will also drive market growth in the coming years.

Poultry Vaccine Market

Moreover, infected meat consumption risks human health, thereby making it imperative that the birds be vaccinated before usage. The main obstacles poultry farms face are the rapid spread of diseases and the lack of treatment options. To prevent such situations, vaccination becomes mandatory. In 2021, the attenuated live vaccines segment held the largest revenue share. Live attenuated vaccines' duration of immunity lasts longer and protects against avian diseases such as infectious bronchitis, infectious bursal disease, and Newcastle disease. Moreover, growing R&D activities, particularly in this field of vaccination, to curb various outbreaks of the diseases mentioned above are accentuating the segment growth.

Poultry Vaccine Market Key Developments

  • In February 2021, Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders.
  • In July 2020, Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health.
  • For instance, in April 2019, according to the Middle East Rating Agency, the Qatar government established central food laboratories with different procedures and analyses on food safety to ensure consumers are provided with contamination-free, safe, and high-quality meat products.

Poultry Vaccines Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Poultry Vaccines Market Dynamics

Across many parts of the world, the poultry industry is expanding and becoming more industrialized. Increased population, increased purchasing power, and urbanization have all been significant growth drivers. Furthermore, growing consumption of meat globally, initiatives are taken by the government, and increasing demand for poultry-related food products are the major factors driving the market's growth. Increasing use of antibiotics and illegal use of vaccines & backyard poultry will hamper the global industry.

Poultry Vaccines Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2.1 billion

Market CAGR

5.9%

By Vaccine Type

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Others

By Application

  • Mareks Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Avian Influenza
  • Coccidiosis
  • Mycoplasma
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The poultry vaccines market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The global poultry vaccines market size was valued at US$ 2.1 billion in 2023 and is expected to grow at a significant CAGR of 5.9% from 2024-2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The market key players are Merck & Co., Inc., Elanco, Boehringer Ingelheim International GmbH, Biovac, Zoetis, Hester Biosciences Limited, KM Biologics, Phibro Animal Health Corporation

Author image

Author

Manoj Kumar

Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....

1.Executive Summary
2.Global Poultry Vaccines Market Introduction 
2.1.Global Poultry Vaccines Market  - Taxonomy
2.2.Global Poultry Vaccines Market  - Definitions
2.2.1.Vaccine Type
2.2.2.Application
2.2.3.Region
3.Global Poultry Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Poultry Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Poultry Vaccines Market  By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Live Attenuated Vaccines
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Poultry Vaccines Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Mareks Disease
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Newcastle Disease
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Infectious Bursal Disease
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Infectious Bronchitis
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Avian Influenza
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Coccidiosis
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Mycoplasma
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Others
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7.Global Poultry Vaccines Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Inactivated Vaccines
8.1.2.Live Attenuated Vaccines
8.1.3.Others
8.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Mareks Disease
8.2.2.Newcastle Disease
8.2.3.Infectious Bursal Disease
8.2.4.Infectious Bronchitis
8.2.5.Avian Influenza
8.2.6.Coccidiosis
8.2.7.Mycoplasma
8.2.8.Others
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Inactivated Vaccines
9.1.2.Live Attenuated Vaccines
9.1.3.Others
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Mareks Disease
9.2.2.Newcastle Disease
9.2.3.Infectious Bursal Disease
9.2.4.Infectious Bronchitis
9.2.5.Avian Influenza
9.2.6.Coccidiosis
9.2.7.Mycoplasma
9.2.8.Others
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Inactivated Vaccines
10.1.2.Live Attenuated Vaccines
10.1.3.Others
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Mareks Disease
10.2.2.Newcastle Disease
10.2.3.Infectious Bursal Disease
10.2.4.Infectious Bronchitis
10.2.5.Avian Influenza
10.2.6.Coccidiosis
10.2.7.Mycoplasma
10.2.8.Others
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Inactivated Vaccines
11.1.2.Live Attenuated Vaccines
11.1.3.Others
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Mareks Disease
11.2.2.Newcastle Disease
11.2.3.Infectious Bursal Disease
11.2.4.Infectious Bronchitis
11.2.5.Avian Influenza
11.2.6.Coccidiosis
11.2.7.Mycoplasma
11.2.8.Others
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Inactivated Vaccines
12.1.2.Live Attenuated Vaccines
12.1.3.Others
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Mareks Disease
12.2.2.Newcastle Disease
12.2.3.Infectious Bursal Disease
12.2.4.Infectious Bronchitis
12.2.5.Avian Influenza
12.2.6.Coccidiosis
12.2.7.Mycoplasma
12.2.8.Others
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Merck & Co., Inc.,
13.2.2.Elanco
13.2.3.Boehringer Ingelheim International GmbH
13.2.4.Biovac
13.2.5.Zoetis
13.2.6.Hester Biosciences Limited
13.2.7.KM Biologics
13.2.8.Phibro Animal Health Corporation
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Merck & Co., Inc.,
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Biovac
  • Zoetis
  • Hester Biosciences Limited
  • KM Biologics
  • Phibro Animal Health Corporation

Related Industry Reports